1. Home
  2. RYTM vs NXST Comparison

RYTM vs NXST Comparison

Compare RYTM & NXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rhythm Pharmaceuticals Inc.

RYTM

Rhythm Pharmaceuticals Inc.

HOLD

Current Price

$114.42

Market Cap

5.8B

Sector

Health Care

ML Signal

HOLD

Logo Nexstar Media Group Inc.

NXST

Nexstar Media Group Inc.

HOLD

Current Price

$176.20

Market Cap

5.4B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
RYTM
NXST
Founded
2008
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Broadcasting
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
5.8B
5.4B
IPO Year
2017
2002

Fundamental Metrics

Financial Performance
Metric
RYTM
NXST
Price
$114.42
$176.20
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
14
8
Target Price
$131.14
$263.75
AVG Volume (30 Days)
992.6K
491.4K
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
3.67%
EPS Growth
28.34
N/A
EPS
N/A
5.09
Revenue
N/A
$4,949,000,000.00
Revenue This Year
$55.34
$11.38
Revenue Next Year
$86.06
N/A
P/E Ratio
N/A
$35.21
Revenue Growth
N/A
N/A
52 Week Low
$74.50
$154.47
52 Week High
$122.20
$254.30

Technical Indicators

Market Signals
Indicator
RYTM
NXST
Relative Strength Index (RSI) 71.54 48.11
Support Level $98.30 $154.47
Resistance Level $122.20 $210.69
Average True Range (ATR) 4.86 7.99
MACD 0.94 2.19
Stochastic Oscillator 91.15 62.85

Price Performance

Historical Comparison
RYTM
NXST

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company engaged in the development and commercialization of therapies for patients with rare neuroendocrine diseases. The company is focused on advancing its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. In addition, it has two early-stage investigational MC4R agonists in clinical development, RM-718 and bivamelagon, designed not to cause hyperpigmentation. The company is also focused on advancing potential candidates for congenital hyperinsulinism. It currently operates in two business segments: the United States, which generates maximum revenue, and International.

About NXST Nexstar Media Group Inc.

Nexstar is the largest television station owner-operator in the United States with over 200 stations in 116 markets, reaching 220 million people. Of its 200 stations, 155 are affiliated with the four national broadcast networks: CBS, Fox, NBC, and ABC. Assuming its merger with Tegna is affirmed Nexstar's station total would exceed 259 and reach 80% of the US population. Nexstar also owns NewsNation (formerly WGN), a cable news network, 75% of the fifth national broadcaster, the CW, and a 31% stake in Food Network and Cooking Channel.

Share on Social Networks: